Walmart Adds Path Fertility’s Sperm Quality Test to Associate Fertility and Family-Building Benefits
Bentonville, Arkansas – August 21, 2024 – Path Fertility, a division of Inherent Biosciences, Inc. and a leading innovator in reproductive health solutions, is excited to announce the addition of its Sperm Quality Test (SpermQT) to Walmart's Fertility and Family-Building Benefits. This collaboration, established through a definitive agreement with Walmart's Fertility Benefit Provider, Kindbody, on July 30, 2024, underscores a shared commitment to enhancing fertility care for Walmart associates nationwide.
SpermQT, known for its advanced assessment of sperm quality, is now integrated into the comprehensive benefits package offered to Walmart associates through Kindbody. This integration is part of Walmart’s ongoing effort to provide robust support for associates’ family-building journeys.
This integration exemplifies Walmart’s choice of Kindbody as a Center of Excellence, a healthcare provider committed to delivering excellent care, addressing the root cause of patients’ conditions, and ensuring an outstanding patient experience.
SpermQT identifies subfertile men often missed by standard semen analysis. For self-insured employers and healthcare benefits providers, this early, accurate detection can reduce ineffective fertility treatments, lower costs, and enhance employee well-being by ensuring that the right fertility interventions are provided from the start.
“Our partnership with Walmart and Kindbody marks a significant milestone in our mission to make advanced fertility solutions accessible to all. Male fertility has historically been underrepresented in reproductive health, yet it is a crucial component of successful fertility outcomes. By including SpermQT in Walmart’s benefits program, we are addressing this critical gap head-on. Path Fertility is committed to ensuring that both men and women have access to the diagnostic tools they need to navigate their fertility journeys with confidence,” said Andy Olson, CEO of Path Fertility.
For more information about Path Fertility and SpermQT, visit pathfertility.com.
About Path Fertility: Path Fertility is pioneering epigenetic diagnostics in reproductive health and dedicated to closing the gap in fertility technology with innovative solutions like SpermQT. The company's commitment to rigorous research and compassionate care underlines their vision of a world where fertility challenges are addressed with equal vigor for both men and women.
About Walmart: Walmart Inc. (NYSE: WMT) is a people-led, tech-powered omnichannel retailer helping people save money and live better — anytime and anywhere — in stores, online, and through their mobile devices. Each week, approximately 255 million customers and members visit more than 10,500 stores and numerous eCommerce websites in 19 countries. With fiscal year 2024 revenue of $648 billion, Walmart employs approximately 2.1 million associates worldwide. Walmart continues to be a leader in sustainability, corporate philanthropy, and employment opportunity. Additional information about Walmart can be found by visiting corporate.walmart.com.
About Kindbody: Kindbody is the leading national fertility clinic network and global family-building benefits provider for employers offering the full spectrum of reproductive care from preconception to postpartum through menopause. Kindbody is the trusted fertility benefits provider for 121 leading employers, covering 3.1 million lives. Many thousands more receive their fertility care directly from Kindbody throughout the country at signature clinics, mobile clinics, and partner clinics. As the fertility benefits provider, technology platform, and direct provider of care, Kindbody delivers a seamless, integrated experience with superior health outcomes at lower cost, making fertility care more affordable and accessible for all. Kindbody has raised $315 million in debt and equity funding from leading investors including Perceptive Advisors, JP Morgan Chase's Morgan Health, GV (formerly Google Ventures), RRE Ventures, Claritas Health Ventures, Rock Springs Capital, Walleye Capital, Bramalea, Monashee Capital, and Whatif Ventures. Visit www.kindbody.com.
